Exhibit 99.1

News Release

LCA-Vision Fourth Quarter Results Feature Growth in Same-Store Procedure Volume

and Improved Operational Metrics

2010 conversion metrics reach highest levels since 2007

CINCINNATI (February 16, 2011) – LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus^® brand, today announced financial and operational results for the three and 12 months ended December 31, 2010.

Fourth Quarter 2010 Operational and Financial Highlights (all comparisons are with the fourth quarter of 2009)

Full Year 2010 Operational and Financial Highlights (all comparisons are with the full year 2009)

Since the first quarter of 2007, LCA-Vision has provided both adjusted revenues and operating losses as a means of measuring performance that adjusts for the non-cash impact of accounting for separately priced extended warranties. A reconciliation of revenues and operating losses as reported in accordance with U.S. Generally Accepted Accounting Principles (GAAP) is provided at the end of this news release. Management believes the adjusted information better reflects operating performance and, therefore, is more meaningful to investors.

“We are reporting tangible results from our actions to improve operations in the current weakened economy while building for future growth and profitability,” stated LCA-Vision Chief Operating Officer David L. Thomas. “Our operational performance significantly improved in 2010, resulting in our best appointment show rate, conversion and treatment show rate since 2007. We were able to improve these metrics while lowering the average acquisition cost per eye to $425 in 2010, from $464 in 2009 and $455 in 2008. We obtained an average price per procedure of $1,652 in 2010, compared with $1,650 in 2009 and $1,619 in 2008.

“For the fourth quarter, we reported a year-over-year increase in same-store procedures of more than 6% – the first increase since the fourth quarter of 2006,” Thomas added. “We attribute this growth to acceptance of our ‘Life in Focus’ marketing campaign, improved operational metrics, a greater willingness of patients to spend on vision correction services and a discount promotion that expired at year-end. Although the December promotion expiration adversely impacted procedure volume in early 2011 as some patients accelerated their procedure dates to take advantage of the discount, we have been gaining some momentum as the first quarter continues. We are cautiously optimistic about the potential impact on our business of recent increases in the consumer confidence index.”

LCA-Vision Chief Financial Officer Michael J. Celebrezze said, “Our cash-conservation initiatives resulted in a $14.1 million decline in operating loss compared with 2009. We generated positive cash from operations, which included an $11.8 million federal income tax refund. For the year, we used $2.7 million in cash and investments after debt service and capital expenditures. We ended the year with nearly $52 million in cash and investments and $7 million in debt obligations. We do not anticipate receiving a federal income tax refund this year and our cash flow will depend largely upon procedure volume.”

As a result of cash-conservation measures, the company lowered the expected number of procedures companywide required for breakeven cash flow, after capital expenditures and debt service, to approximately 70,000 per year, down from 73,000 previously. The company believes that it has sufficient cash and investments to fund its business beyond 2012 if it performs at least 47,000 procedures annually, compared with the previous expectation of 52,000. The company believes that it has sufficient cash and investments to fund its business beyond 2013 at 52,500 procedures annually. The average number of procedures required for each vision center to reach breakeven remains at 95 per month.

2

“We are taking actions to diversify into related eye-health businesses to leverage our capabilities and resources, drive more revenue through our existing vision centers, capitalize on our more than half-million past patients and high patient satisfaction rate, and lessen the impact of future economic downturns,” added Celebrezze. “Our focus is on programs that require minimal investment that can be rolled out in a modular approach, allowing for phased introductions. As an example, during the fourth quarter, we added over-the-counter eye drop products in our full LasikPlus^® network, which generated nearly $40,000 of revenue in January 2011. We also are evaluating a co-management/management services offering designed to generate revenue by attracting patients to LasikPlus^® and offering provisional services to optometrists, as well as potential expansion into cataract and intraocular lens surgery, which targets the fast-growing aging population.”

Near-term Financial Outlook

LCA-Vision intends to manage expenses conservatively in 2011. The company’s plans and outlook for the year include:

Conference Call and Webcast

As previously announced, a conference call and webcast will be held today beginning at 10:00 a.m. Eastern time. To access the conference call, dial 866-322-1352 (U.S. and Canada) or 706-643-6246 (international callers). The webcast will also be available in the investor relations section of LCA-Vision’s website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 800-642-1687 (U.S. and Canada) or 706-645-9291 (international callers) and enter the conference ID number: 33127343.

Forward-Looking Statements

This news release contains forward-looking statements based on current expectations, forecasts and assumptions of LCA-Vision that are subject to risks and uncertainties. The forward-looking statements in this release are based on information available to the company as of the date hereof. Actual results could differ materially from those stated or implied in the forward-looking statements due to risks and uncertainties associated with its business. In addition to the risk factors discussed in the company’s Form 10-K and other filings with the Securities and Exchange Commission, there are a number of other risks and uncertainties associated with its business, including, without limitation, the successful execution of cost effective marketing strategies to drive patients to its vision centers; the impact of low consumer confidence and discretionary spending; competition in the laser vision correction industry; the company’s ability to attract patients; the possibility of adverse outcomes or long-term side effects of laser vision correction and negative publicity regarding laser vision correction; the company’s ability to operate profitable vision centers and retain qualified personnel during periods of lower procedure volumes; the continued availability of non-recourse third-party financing for its patients on terms similar to what it has paid historically; and the future value of revenues financed by the company and its ability to collect on such financings, which will in turn depend on a number of factors, including the consumer credit environment and the company’s ability to manage credit risk related to consumer debt, bankruptcies and other credit trends.

Further, the FDA’s advisory board on ophthalmic devices is currently reviewing concerns about post-LASIK quality of life matters, and the FDA has begun a major new study on LASIK outcomes and quality of life that is expected to end in 2012. The FDA or another regulatory body could take legal or regulatory action against the company or others in the laser vision correction industry. The outcome of this review or legal or regulatory action could potentially impact negatively the acceptance of LASIK. In addition, the acceptance rate of new technologies and our ability to implement successfully new technologies on a national basis create additional risk. Except to the extent required under the federal

3

securities laws and the rules and regulations promulgated by the Securities and Exchange Commission, the company assumes no obligation to update the information included in this news release, whether as a result of new information, future events or circumstances, or otherwise.

About LCA-Vision Inc./LasikPlus^®

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus^® brand, operates 54 LasikPlus^® fixed-site laser vision correction centers in 26 states and 41 markets in the United States. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment; Building Relationships for a Lifetime.

4

LCA-Vision Inc.

Consolidated Statement of Operations

(Dollars in thousands except per share data)

(Unaudited)

5

LCA-Vision Inc.

Consolidated Balance Sheets

(Dollars in thousands)

(Unaudited)

6

LCA-Vison Inc.

Consolidated Statements Of Cash Flows

(Dollars in thousands)

(Unaudited)

7

LCA-Vision Inc.

Effect of the Change in Accounting for Deferred Revenues on Financial Results

(Dollars in thousands)

(Unaudited)

To supplement its Condensed Consolidated Financial Statements presented in accordance with accounting principles generally accepted in the United States, LCA-Vision discusses adjusted revenues and operating income. Management utilizes this information as a means of measuring performance that adjusts for the non-cash impact of the accounting for separately priced extended warranties and believes that including this additional disclosure is meaningful to investors for the same reason.

Accordingly, this news release contains non-GAAP financial measures within the meaning of Regulation G promulgated by the Securities and Exchange Commission. A reconciliation of the difference between the non-GAAP measures with the most directly comparable financial measures calculated in accordance with GAAP follows:

# # #

8